The merged data suggested that the RBP-4 levels in patients with psoriasis vulgaris after treatment were similar to the levels in control subjects (SMD = 0.14, 95%CI: −0.38, 0.66, p > 0.05; Figure 4). This evidence concerns the gene RBP4 and psoriasis vulgaris.